1-Piperonylpiperazine → HCID 178419743, compound
Reaction equation
[Br:1][CH2:2][CH:3]1[CH2:16][N:6]2[C:7](=[O:15])[NH:8][C:9]3[CH:10]=[CH:11][CH:12]=[CH:13][C:14]=3[C:5]2=[N:4]1.[CH2:17]([N:27]1[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]1)[C:18]1[CH:26]=[CH:25][C:24]2[O:23][CH2:22][O:21][C:20]=2[CH:19]=1>C(#N)C>[BrH:1].[CH2:17]([N:27]1[CH2:32][CH2:31][N:30]([CH2:2][CH:3]2[CH2:16][N:6]3[C:7](=[O:15])[NH:8][C:9]4[CH:10]=[CH:11][CH:12]=[CH:13][C:14]=4[C:5]3=[N:4]2)[CH2:29][CH2:28]1)[C:18]1[CH:26]=[CH:25][C:24]2[O:23][CH2:22][O:21][C:20]=2[CH:19]=1.[CH3:2][CH:3]1[CH2:16][N:6]2[C:7](=[O:15])[NH:8][C:9]3[CH:10]=[CH:11][CH:12]=[CH:13][C:14]=3[C:5]2=[N:4]1Participants
Reactant 2
Product 2
Reagents, catalysts & solvents 1
Procedure
A mixture of 2-bromomethyl-2,3-dihydroimidazo[1,2-c]-quinazolin-5(6H)-one (0.5 g, 1.78 mmol), 1-piperonylpiperazine (0.78 g, 3.56 mmol) in acetonitrile (25 mL) was refluxed for 17 hours. The solvent was then removed in vacuo to the oily residue. The residue was purified by column chromatography [silica gel: 25 g, column diameter: 2.5 cm, solvent system: chloroform/ethylacetate (9/1)] to furnish 2-[4-piperonyl-1-piperazinyl]methyl-2,3-dihydroimidazo[1,2-c]-quinazolin-5(6H)-one hydrobromide (620 mg, 67%) and 2-methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one (90 mg, 22%). 2-[4-piperonyl-1-piperazinyl]methyl-2,3-dihydroimidazo[1,2-c]-quinazolin-5(6H)-one hydrobromide: mp 236°-238° C. Anal. Calcd for C23H23N5O3 /H2O/HBr: C, 53.29; H, 5.44; N, 13.50. Found: C, 53.45; H, 5.46 ; N, 13.54.
Workup
- temperaturewas refluxed for 17 hours
- customThe solvent was then removed in vacuo to the oily residue
- customThe residue was purified by column chromatography [silica gel: 25 g, column diameter: 2.5 cm, solvent system: chloroform/ethylacetate (9/1)]
Sources & evidence
- ORD record
- ord-4dfeb3a9e7a04fab833fe6c2b1ff162b
- Source dataset
- uspto-grants-1992_10
- Patent number
- US05158953
Reaction notes
Loading…